Results 191 to 200 of about 947,807 (342)
Uterine Adenomyosarcoma Complicated by Uterine Prolapse and Necrosis: A Case Report [PDF]
Jiahao Chang,1 Yanqing Jin,2 Chaoxiong Cui,3 Haiyan Cheng4 1Department of Gynecology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People’s Republic of China; 2Department of Abdominal Ultrasound, Qingdao ...
Chang J, Jin Y, Cui C, Cheng H
core
Merkel cell carcinoma: an updated guide for pathologists
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine carcinoma for which the differential diagnosis can include other small cell malignancies (especially metastatic small cell carcinoma) or cutaneous carcinoma. Morphologic and immunophenotypic aberrancies in MCC can increase diagnostic challenge.
Paul W. Harms
wiley +1 more source
Squamous Cell Carcinoma of the Uterine Cervix With Myxoid/Sarcomatoid Morphology. [PDF]
Yokoo K +4 more
europepmc +1 more source
HMGA2 is a highly sensitive marker for DICER1‐related tumours
Aims DICER1 is a microRNA biogenesis enzyme that, when mutated, results in a rewiring of the transcriptome. Germline pathogenic variants (PVs) in DICER1 result in DICER1‐related tumour predisposition (DRTP) characterized by 30 or more different, generally rare, paediatric or adolescent‐onset tumours.
Paul S. Thorner +5 more
wiley +1 more source
Broad Ligament Fibroid Mimicking an Ovarian Tumor: A Case Report. [PDF]
Ghuge RS +4 more
europepmc +1 more source
This review provides an update on the epidemiology, pathogenesis, and clinical/histologic features of cutaneous leiomyosarcoma. Prognostic factors (e.g., depth of tumor involvement, grade, etc.) that can facilitate risk stratification are also discussed, as are treatment approaches for this rare malignancy.
Tejas P. Joshi +4 more
wiley +1 more source
ABSTRACT Objectives To evaluate the status and methodological quality of randomized controlled trials published in 2024 on Chinese patent medicines and Classic Traditional Chinese Medicine Prescriptions, providing evidence for clinical practice and policy.
Xiaolei Wu +14 more
wiley +1 more source

